...
首页> 外文期刊>BioMed research international >Delivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) In Vivo
【24h】

Delivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) In Vivo

机译:直接应用siRNA体内诱导RNA干扰(RNAi)的递送系统

获取原文
   

获取外文期刊封面封底 >>

       

摘要

RNA interference (RNAi) is a powerful method for specific genesilencing which may also lead to promising novel therapeuticstrategies. It is mediated through small interfering RNAs (siRNAs)which sequence-specifically trigger the cleavage and subsequentdegradation of their target mRNA. One critical factor is theability to deliver intact siRNAs into target cells/organs in vivo.This review highlights the mechanism of RNAi and the guidelinesfor the design of optimal siRNAs. It gives an overview of studiesbased on the systemic or local application of naked siRNAs or theuse of various nonviral siRNA delivery systems. One promisingavenue is the the complexation of siRNAs with the polyethylenimine(PEI), which efficiently stabilizes siRNAs and, upon systemicadministration, leads to the delivery of the intact siRNAs intodifferent organs. The antitumorigenic effects ofPEI/siRNA-mediated in vivo gene-targeting of tumor-relevantproteins like in mouse tumorxenograft models are described.
机译:RNA干扰(RNAi)是一种用于特异发生的强大方法,也可能导致有希望的新型治疗策略。它是通过小的干扰RNA(siRNA)介导的,这些干扰RNA序列特异性地触发了其靶mRNA的裂解和随后的降解。一个关键因素是能否将完整的siRNA体内递送至靶细胞/器官。这篇综述着重介绍了RNAi的机制以及最佳siRNA设计的指导原则。它概述了基于裸siRNA的全身或局部应用或各种非病毒siRNA递送系统的使用的研究。 siRNA与聚乙烯亚胺(PEI)的络合是一种有希望的途径,它可以有效地稳定siRNA,并且在全身给药后可将完整的siRNA传递到不同的器官中。描述了PEI / siRNA介导的肿瘤相关蛋白体内基因靶向的抗肿瘤作用,例如在小鼠肿瘤异种移植模型中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号